FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zosano Pharma Corporation (NASDAQ: ZSAN) Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System”
Zosano Pharma Corporation (NASDAQ: ZSAN) surged over 35% in premarket trading after announcing the successful formulation of a COVID-19 vaccine candidate on its microneedle patch system.
Zosano’s patch consists of an array of approximately two thousand drug-coated titanium microneedles mounted on an adhesive patch that is administered to the skin using a reusable applicator.
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company’s transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano’s lead product candidate is M207, which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine.
For more information, please visit: Zosano Pharma Corporation
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.